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A large number of epidemiologic studies
have found an association between short-
term episodes of increased particulate air pol-
lution and cardiovascular morbidity and
mortality (Brook et al. 2004). Respirable
particulate matter has been speciﬁcally impli-
cated in the triggering of myocardial infarction
(D’Ippoliti et al. 2003; Peters et al. 2001),
arrhythmias (Peters et al. 2000), decompen-
sation of heart failure patients (Morris and
Naumova 1998; Schwartz and Morris 1995;
Wellenius et al., in press), and the exacerbation
of myocardial ischemia (Pekkanen et al. 2002;
Wellenius et al. 2003). Particulate-related
changes in autonomic nervous system activity,
as assessed by heart rate variability, have been
observed in both experimental animal studies
(Godleski et al. 2000) and human panel stud-
ies (Creason et al. 2001; Gold et al. 2000;
Liao et al. 1999, 2004; Pope et al. 1999), sug-
gesting sympathetic activation or vagal
suppression after particulate air pollution
exposure. Such changes in autonomic tone
may increase the risk of ventricular arrhyth-
mias in vulnerable patients (Huikuri et al.
2001). Ventricular tachyarrhythmias, primar-
ily ventricular tachycardia and ventricular ﬁb-
rillation, are common precursors to sudden
cardiac death (Bayes de Luna et al. 1989;
Myerburg et al. 1992).
Implanted cardioverter defibrillators
(ICDs) passively monitor for ventricular tach-
yarrhythmias that, if not terminated, could
be life threatening. On detecting such an
arrhythmia, the ICD can apply cardiac pacing
or cardioverter shock to restore normal
rhythms. The ICD also records the date and
time of arrhythmias plus intracardiac electro-
grams immediately before and during these
events. In a pilot study of 100 Boston area
ICD patients with follow-up for up to
3 years, we found increased risk of an ICD
therapeutic discharge on days after elevated
air pollution concentrations (Peters et al.
2000). In this pilot study, we did not collect
data on patient characteristics or medication.
However, we did find stronger air pollution
associations among patients with frequent
ICD discharges.
This study was designed to confirm the
pilot study observations. In a larger sample of
ICD patients in Boston with longer follow-
up, we identiﬁed ventricular tachyarrhythmias
by review of ICD-recorded electrograms. We
assessed the association between community
air pollution and ventricular tachyarrhythmias
using time-series methods. We also evaluated
modification of the air pollution association
by patient medical conditions, antiarrhythmic
medications, and recent arrhythmias.
Materials and Methods
Arrhythmias. We examined the effects of air
pollution on incidence of tachyarrhythmias
in ICD patients clinically followed between
July 1995 and July 2002 at the Tufts New
England Medical Center (Dockery et al., in
press). The source population consisted of
patients implanted with third-generation
Guidant ICDs (Cardiac Pacemakers, Inc.,
St. Paul, MN) at the New England Medical
Center Cardiac Electrophysiology and
Pacemaker Laboratory between June 1995
and 31 December 1999. All patients met the
American College of Cardiology and the
American Heart Association guidelines for
ICD implantation (Gregoratos et al. 1998).
We excluded patients residing in ZIP codes
> 40 km (25 miles) from the air monitoring
site at the Harvard School of Public Health.
Patient characteristics before implant (includ-
ing age, sex, race and ethnicity, residential ZIP
code, implant date, device model, diagnoses at
implant, and physiologic measurements before
implant) were abstracted from patient records.
Prescribed medications were abstracted from
clinical records at each follow-up visit.
Date, time, and intracardiac electrograms
of all detected arrhythmias were downloaded
from the ICD records collected at the patients’
regular clinical follow-up visits (on average,
every 89 days). Patients contributed person-
time to the follow-up between ICD implanta-
tion and their last clinical follow-up visit at
the New England Medical Center before July
2002. We excluded the first 14 days after
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Epidemiologic studies have demonstrated a consistent link between sudden cardiac deaths and
particulate air pollution. We used implanted cardioverter deﬁbrillator (ICD) records of ventricular
tachyarrhythmias to assess the role of air pollution as a trigger of these potentially life-threatening
events. The study cohort consisted of 203 cardiac patients with ICD devices in the Boston metro-
politan area who were followed for an average of 3.1 years between 1995 and 2002. Fine particle
mass and gaseous air pollution plus temperature and relative humidity were measured on almost all
days, and black carbon, sulfate, and particle number on a subset of days. Date, time, and intracar-
diac electrograms of ICD-detected arrhythmias were downloaded at the patients’ regular follow-up
visits (about every 3 months). Ventricular tachyarrhythmias were identiﬁed by electrophysiologist
review. Risk of ventricular arrhythmias associated with air pollution was estimated with logistic
regression, adjusting for season, temperature, relative humidity, day of the week, patient, and a
recent prior arrhythmia. We found increased risks of ventricular arrhythmias associated with 2-day
mean exposure for all air pollutants considered, although these associations were not statistically
significant. We found statistically significant associations between air pollution and ventricular
arrhythmias for episodes within 3 days of a previous arrhythmia. The associations of ventricular
tachyarrhythmias with fine particle mass, carbon monoxide, nitrogen dioxide, and black carbon
suggest a link with motor vehicle pollutants. The associations with sulfate suggest a link with
stationary fossil fuel combustion sources. Key words: air pollution, arrhythmias, epidemiology,
fibrillation, heart arrest. Environ Health Perspect 113:670–674 (2005). doi:10.1289/ehp.7767
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hospital inpatient, and periods between clinical
visits when the patient was not followed up at
the New England Medical Center. Subjects
who died or who were lost to follow-up were
censored at their last clinical follow-up.
The intracardiac electrograms for each
ICD-detected arrhythmia were reviewed by an
electrophysiologist (M.S.L.) blinded to air pol-
lution levels. Ventricular tachyarrhythmias
were identified based on atrial-ventricular
dysynchrony, onset interval, stability, mor-
phology of the tachycardia, and response to
therapy. We excluded sinus tachycardias,
arrhythmias originating outside the ventricle
(e.g., atrial tachycardia, atrial ﬁbrillation, atrial
ﬂutter, sinus tachycardia), and noise or over-
sensing events. An episode day was deﬁned as
one or more ventricular arrhythmic events on a
given calendar day.
Data collection and preliminary analyses
have been described previously (Dockery
et al., in press). The Harvard School of Public
Health Human Studies Committee and the
New England Medical Center Institutional
Review Board approved this retrospective
record review.
Air pollution. Ambient concentrations of
gaseous air pollutants were measured by the
Massachusetts Department of Environmental
Protection between 1995 and 2002 at six sites
for ozone, nitrogen dioxide, and/or sulfur
dioxide and four sites for carbon monoxide in
the Boston metropolitan area. We calculated
the average air pollution concentration across
the reporting air pollution monitoring sta-
tions for each hour accounting for differences
in the annual mean and the standardized
deviations of each monitor (Schwartz 2000).
The daily mean was then calculated from the
24-hr specific average concentrations across
the monitors.
Fine particulate (< 2.5 µm aerodynamic
diameter) matter (PM2.5) concentrations were
measured (model 1400A tapered element
oscillating microbalance; Rupprecht and
Patashnick, East Greenbush, NY) at an ambi-
ent monitoring site in South Boston between
15 January 1995 and 19 January 1998 and at
the Harvard School of Public Health starting
on 17 March 1999. Particulate black carbon
(BC) was measured (aethalometer model 8021;
McGee Scientiﬁc, Berkeley, CA) at the South
Boston site through 29 March 1997 and at the
Harvard School of Public Health site starting
on 15 October 1999. Daily particulate sulfate
(SO4) was measured by ion chromatography
(model 120; Dionex, Sunnyvale, CA) starting
on 25 September 1999, and particle number
(PN) by condensation particle counter (TSI
Inc., Shoreview, MN) starting on 13 October
1999. We did not consider PM10 (particulate
matter with a diameter < 10 µm), which was
measured on a 1-in-6–day schedule.
The hourly surface observations from the
National Weather Service at Logan Airport
in East Boston were extracted from climatic
records (Earth-Info, Inc., Boulder, CO).
Daily minimum temperature and mean rela-
tive humidity were calculated from the hourly
observations.
Statistical analyses. Following the analytic
methods used in the pilot study (Peters et al.
2000), we assessed the association of arrhyth-
mias with air pollution using time-series meth-
ods. We merged the patient-speciﬁc record of
days on study and ICD-detected ventricular
arrhythmias with the daily mean air pollution
and weather measurements. The association of
arrhythmic episode-days with air pollution
was analyzed by logistic regression using gen-
eralized estimating equations (Diggle 1988;
Zeger et al. 1988) with random effects for
patients, a linear trend, sine and cosine terms
with periods of one, one-half, one-third, and
one-quarter year, quadratic functions of mini-
mum temperature and mean humidity, indi-
cators for day of the week, and an indicator
for a previous arrhythmia within 3 days.
We considered mean air pollution con-
centrations on the same day and lags of 1, 2,
and 3 days. The lag structure of the data was
estimated by evaluating each lag day (0 to 3)
separately and jointly in an unconstrained dis-
tributed lag model (Pope and Schwartz
1996). We have found consistently elevated
(although not statistically signiﬁcant) risk esti-
mates associated with air pollution concen-
trations on the day of (lag 0) and the day
before (lag 1) the arrhythmia (Dockery et al.,
in press). Therefore, in this article we report
only the effects of 2-day running mean air
pollution concentrations.
We explored potential modiﬁcation of the
air pollution associations in multivariate logis-
tic regression including interactions between
air pollution and indicators of patient charac-
teristics. Patients were stratified by reported
ejection fraction before implantation (≤ 35%
vs. > 35%), prior myocardial infarction, and
the diagnosis of coronary artery disease before
implantation (not sufficient numbers of
patients for speciﬁc analyses of other cardiac
diagnoses). We assessed modification of the
air pollution associations by usual prescribed
medications (reported at more than half of
clinical follow-ups) grouped as beta-blockers,
digoxin, and other antiarrhythmics (amio-
darone, sotalol, mexilitine, and quinidine).
The strongest predictor of a ventricular
arrhythmia was an arrhythmia in the previous
3 days. Therefore, in addition to controlling
for prior arrhythmias, we assessed the modiﬁ-
cation of the air pollution association by a
prior ventricular arrhythmia.
We present odds ratios (ORs) and 95%
confidence intervals (CIs) based on an
interquartile range (25th percentile–75th
percentile) increase in each air pollution con-
centration. p-Values are reported for the
effects of air pollution and for the interactions
of air pollution with posited effect modiﬁers.
We characterize p-values < 0.05 as statistically
signiﬁcant, and p-values < 0.10 as marginally
significant. For air pollutants and subgroups
of events with statistically signiﬁcant associa-
tions, we examined the risk of arrhythmias
versus quintiles of air pollution concentration.
Results
Patient population. A total of 307 patients
had Guidant ICDs implanted at the New
England Medical Center between June 1995
and the end of 1999. There were 203 patients
followed up with residential ZIP codes within
40 km (25 miles) of the ambient air pollution
monitoring site at the Harvard School of
Public Health. These ICD patients had a
total of 635 person-years (pyr) of follow-up or
an average of 3.1 years per subject.
There were 933 ICD-detected tachy-
arrhythmias (separated by at least 60 min), of
which 798 (86%) were ventricular (63 ventric-
ular fibrillation, 25 nonsustained ventricular
fibrillation, 622 ventricular tachycardia, and
88 nonsustained ventricular tachycardia). We
restricted analysis to the 670 ventricular episode
days (one or more ventricular arrhythmias on a
calendar day), average of 1.06 episode days/pyr,
among 84 (41%) patients.
Patients were predominantly men (75%)
with an average age at implantation of 64 years
(range, 19–90 years). The rate of ventricular
episode days per person-year was higher among
men (1.22/pyr) compared with women
(0.62/pyr), and increased with age at implanta-
tion. Eighty-three percent of the patients were
reported to be white, 3% African American,
5% Hispanic, 3% Asian, and 7% of undeter-
mined or unknown race/ethnicity.
Among the patients reported to have had
a myocardial infarction before ICD implan-
tation, the rate of ventricular arrhythmias
(1.73/pyr) was almost three times the rate
among the patients without a prior myocar-
dial infarction (0.61/pyr). The patients with
low ejection fraction (≤ 35%) before implan-
tation had a rate of ventricular episodes
(1.48/pyr) approximately three times larger
than that of patients with ejection fraction
> 35% (0.45/pyr).
The most common preimplantation diag-
nosis was coronary artery disease (70%) fol-
lowed by cardiomyopathy (36%). Nine
patients (4%) were classiﬁed as having primary
electrical disease, and four of these had ven-
tricular arrhythmic events. Four patients (2%)
had long QT syndrome (a congenital disorder
characterized by prolongation of the QT inter-
val on the electrocardiogram), but only one of
these had an event during follow-up. Patients
with coronary artery disease had the highest
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(1.30/pyr) compared with those with other
diagnoses (0.50/pyr).
Eighty-nine percent of these patients were
prescribed antiarrhythmic medications. The
rates of ventricular arrhythmic episode days
was higher among those prescribed digoxin
(1.68/pyr) or other antiarrhythmics (1.45/pyr)
than among those prescribed beta-blockers
(0.92/pyr) or no regular antiarrhythmic
medication (0.88/pyr).
Approximately one-quarter (164) of the
670 ventricular arrhythmias followed a previ-
ous ventricular arrhythmia within 3 days. We
found that having a prior arrhythmia (within
3 days) was a very strong predictor for a sub-
sequent arrhythmia (OR = 7.2; 95% CI,
5.9–8.9).
Air pollution. PM2.5 was measured on
2,005 (79%) of the follow-up days and BC on
1,533 (60%) days (Table 1). Particulate SO4
measurements were limited to 908 (36%)
days, and PN to 772 (30%) days. Daily PM2.5
was strongly correlated with SO4 (Pearson cor-
relation r = 0.74) and BC (r = 0.67), but only
weakly correlated (r = –0.13) with PN.
The gaseous pollutants were measured on
essentially all follow-up days (Table 1). Daily
CO and NO2, both indicators of motor vehi-
cle emissions, were highly correlated with
each other (r = 0.61), positively correlated
(r > 0.4) with BC, PM2.5, and SO2, but nega-
tively correlated with O3.
Air pollution association. We found posi-
tive associations between ventricular arrhyth-
mic episode days and mean air pollution on
the same and previous days, but none of these
associations approached statistical signiﬁcance
(Table 2).
We did not ﬁnd consistent increased sus-
ceptibility to the effects of air pollution on risk
of ventricular arrhythmias based on patient
characteristics. We found marginally signifi-
cant (p < 0.10) interaction of the associations
with CO with ejection fraction (stronger with
low ejection fraction), preimplantation diag-
nosis of coronary artery disease (weaker with
coronary artery disease), and prior myocardial
infarction (weaker with prior myocardial
infarction), and of the associations with NO2
with prior myocardial infarction (stronger
with prior myocardial infarction). No other
interactions approached statistical signiﬁcance.
We saw no evidence that any of the prescribed
drugs modiﬁed the associations of ventricular
arrhythmias with air pollution.
The interaction of a prior ventricular
arrhythmia with air pollution was statistically
signiﬁcant for PM2.5, BC, NO2, SO2, and CO
and marginally signiﬁcant for SO4 (Table 3).
For ventricular arrhythmias within 3 days of a
prior event (Table 3), we found statistically sig-
niﬁcant positive associations with PM2.5, BC,
NO2, CO, and SO2, marginally significant
associations with SO4, but no associations
with O3 or PN. For ventricular arrhythmias
more than 3 days after a previous ventricular
arrhythmia, we found no associations with any
air pollutants (Table 3). We assessed the risk
of ventricular arrhythmias stratiﬁed by a prior
ventricular tachyarrhythmia versus quintiles of
air pollution (Figure 1). We found generally
increasing risk with increasing quintiles of
PM2.5, BC, and CO and weaker suggestions
of an exposure response with NO2, SO2,
and O3.
Discussion
In this study of 203 New England Medical
Center ICD patients living in the Boston
metropolitan area with up to 7 years of follow-
up, we found the risk of any ICD-detected
ventricular tachyarrhythmia was positively but
not significantly associated with increased
exposure to air pollution on the days before
the arrhythmia (Table 2). We found statisti-
cally significant associations of air pollution
with increased risk of ventricular arrhythmias
among patients with an arrhythmia within the
previous 3 days. These findings suggest that
air pollution may provoke ventricular tach-
yarrhythmias only in the presence of acutely
predisposing conditions that increase ven-
tricular electrical instability. We did not ﬁnd
consistent indications that the air pollution
associations with ventricular arrhythmias were
modiﬁed by indicators of chronically impaired
cardiac function, including a prior myocardial
infarction, a diagnosis of coronary artery
disease, or an ejection fraction < 35%, or by
prescribed antiarrhythmic medications.
These results are broadly consistent with
those of previously published studies of air
pollution associations with tachyarrhythmias
leading to ICD therapeutic discharge. In this
study, we found signiﬁcantly increased risk of
Article | Dockery et al.
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Table 1. Distribution of the 2-day mean air pollutants averaged across multiple sites in Boston, and
weather data: 11 July 1995 to 11 July 2002.
Percentile
Air pollutant No. 25th 50th 75th 95th
PM2.5 (µg/m3) 2,005 7.5 10.3 14.4 23.3
BC(µg/m3) 1,533 0.66 0.98 1.39 2.25
SO4 (µg/m3) 908 1.76 2.55 3.80 7.18
PN (103/cm3) 772 20.6 29.3 39.8 50.7
NO2 (ppb) 2,556 18.9 22.7 26.6 33.6
CO (ppm) 2,558 0.53 0.80 1.02 1.37
SO2 (ppb) 2,558 3.3 4.9 7.4 12.8
O3 (ppb) 2,548 15.7 22.9 31.1 42.1
Minimum temperature (°C) 2,553 0.6 7.2 14.4 20.6
Relative humidity (%) 2,549 56.7 69.0 81.5 94.3
Table 2. Estimated ORs (95% CIs) for an interquartile range increase in 2-day mean air pollution.
No. of days Interquartile range increase OR (95% CI) p-Value
PM2.5 2,005 6.9 µg/m3 1.08 (0.96–1.22) 0.21
BC 1,533 0.74 µg/m3 1.11 (0.95–1.28) 0.18
SO4 908 2.04 µg/m3 1.05 (0.92–1.20) 0.48
PN 772 19,120/cm3 1.14 (0.87–1.50) 0.35
NO2 2,556 7.7 ppb 1.07 (0.97–1.18) 0.19
CO 2,558 0.48 ppm 1.14 (0.95–1.29) 0.28
SO2 2,558 4.0 ppb 1.04 (0.94–1.14) 0.28
O3 2,548 15 ppb 1.09 (0.93–1.29) 0.28
Table 3. Association of interquartile range increase in 2-day mean air pollution with ventricular arrhythmias
stratiﬁed by a recent arrhythmia (within 3 days).
Air pollutant (IQR increase) > 3 Days < 3 Days p-Value for interaction
PM2.5 (6.9 µg/m3) 0.98 (0.86–1.12) 1.60 (1.30–1.96) < 0.001
p = 0.73 p < 0.001
BC (0.74 µg/m3) 1.02 (0.83–1.24) 1.74 (1.28–2.37) 0.003
p = 0.86 p < 0.001
SO4 (2.04 µg/m3) 1.03 (0.87–1.22) 1.19 (0.99–1.43) 0.066
p = 0.73 p = 0.060
PN (19,120/cm3) 1.17 (0.82–1.66) 1.11 (0.71–1.75) 0.86
p = 0.38 p = 0.65
NO2 (7.7 ppb) 1.02 (0.90–1.16) 1.34 (1.05–1.71) 0.050
p = 0.78 p = 0.018
CO (0.48 ppm) 1.04 (0.83–1.29) 1.65 (1.17–2.33) 0.016
p = 0.75 p = 0.005
SO2 (4 ppb) 0.98 (0.87–1.11) 1.30 (1.06–1.61) 0.006
p = 0.78 p = 0.013
O3 (15 ppb) 1.14 (0.92–1.40) 1.01 (0.76–1.35) 0.44
p = 0.24 p = 0.94ventricular arrhythmias with PM2.5, BC, CO,
NO2, and SO2 among patients with a recent
prior ventricular arrhythmia. In the pilot study
(Peters et al. 2000), ICD patients in Boston
with frequent (> 10) discharges during follow-
up had an exposure related increase in
ICD discharge associated with PM2.5, BC,
CO, and NO2.
A recent study assessed the association of
air pollution in Vancouver, British Columbia,
Canada, with ICD discharges among 50
patients with an average of 2.2 years of follow-
up (Rich et al. 2004; Vedal et al. 2004). In
crude analyses, the rate of ICD discharge
increased with quartiles of NO2 and CO con-
centration on the same day (Vedal et al. 2004).
However, there were no statistically signiﬁcant
positive associations with ICD discharge with
NO2 or CO after adjusting for temporal pat-
terns and numerous weather parameters. The
lack of signiﬁcant associations may be caused
by overcontrol of some variables, as these
investigators suggest.
Both of these previously reported studies
(Peters et al. 2000; Vedal et al. 2004) focused
on ICD therapeutic discharge without char-
acterization or validation of the underlying
arrhythmia. Of the almost 2,000 arrhythmias
identiﬁed and recorded by the ICD devices in
this study, 8% were classiﬁed as oversensing,
4% were sinus tachycardias, 18% were supra-
ventricular arrhythmias, and 70% were ven-
tricular arrhythmias. Thus, 30% of the ICD-
detected arrhythmias were not the potentially
life-threatening ventricular tachyarrhythmias
deﬁned as the primary outcome for this study.
An important question in these analyses is
the appropriate exposure averaging time and
the lag between exposure and cardiac arrhyth-
mia. In the pilot study, we found associations
with air pollutants 2 days before the arrhyth-
mias and with the 5-day mean air pollution
(Peters et al. 2000). In this study, ventricular
arrhythmias were positively associated with
ambient air pollution on the same and the
previous calendar days. Temporality would
require that air pollution exposure precede the
arrhythmia. This temporal association is
clearly true for associations with air pollution
on the previous day, but mean air pollution
on the same calendar day would include hours
after as well as before the detected arrhythmia.
Using the pollutant concentrations from the
speciﬁc 24 hr preceding the arrhythmia would
likely provide a better estimate of each sub-
ject’s exposure and allow investigation of
exposures in the hours before the arrhythmia.
For these patients living in eastern
Massachusetts, air pollution exposure was
estimated based on a single or a small number
of monitors in the Boston metropolitan area.
This would lead to misclassification of air
pollution exposure, but this misclassiﬁcation
would be independent of the risk for ven-
tricular arrhythmias. Such nondifferential
misclassification of exposure produces an
attenuated estimate of associations (and larger
CIs) in epidemiologic studies assuming linear
associations. If these observations are true,
then studies with improved estimation of sub-
ject speciﬁc air pollution exposures would be
expected to find stronger, more statistically
signiﬁcant associations.
We found associations with CO, NO2,
BC, and PM2.5. These four pollutants had
high day-to-day correlations with each other
and were strongly correlated with SO2. It
would not be possible to differentiate the
independent effects of these pollutants.
Nevertheless, the associations with these spe-
cific pollutants are consistent with an effect
from air pollution from motor vehicle sources.
Animal studies in Boston have suggested
that changes in indicators of cardiac function
are speciﬁcally associated with motor vehicle
pollution (Clarke et al. 2000). Analysis of
daily mortality in Boston and ﬁve other cities
suggested that motor vehicle pollution was
more strongly related to cardiovascular mortal-
ity than to respiratory mortality (Laden et al.
2000). Cardiovascular emergency department
visits in Atlanta, Georgia, were significantly
associated with these same markers of motor
vehicle air pollution—NO2, CO, PM2.5, BC,
and ﬁne particle organic carbon (Metzger et al.
2004). For Atlanta emergency department vis-
its for dysrhythmias, positive associations were
found for these same motor vehicle pollutants,
although these associations were not statisti-
cally signiﬁcant because of the smaller number
of events.
We cannot exclude the possible role of
sulfur oxides, which are generally considered
to be indicators of air pollution from power
plants and other stationary fossil fuel com-
bustion sources. In this analysis, we found
associations of ventricular tachyarrhythmias in
subjects with a recent event associated with
SO2 (p = 0.013) and with SO4 (p = 0.06). The
positive, marginally signiﬁcant associations with
SO4 are notable because SO4 data were avail-
able only on a limited number of days (37%)
compared with SO2 and the other gaseous
pollutants. Particulate SO4 concentrations in
Article | Air pollution and ventricular arrhythmias
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Figure 1. Relative odds and 95% CIs of ventricular arrhythmias versus quintiles of air pollution, ≤ 3 days of
and > 3 days after, a previous arrhythmia: (A) PM2.5, (B) BC, (C) CO, (D) NO2, (E) SO2, (F) O3.
#p < 0.10; *p < 0.05; **p < 0.01.Article | Dockery et al.
674 VOLUME 113 | NUMBER 6 | June 2005 • Environmental Health Perspectives
Boston largely reflect secondary particles
formed during long-range transport. Gaseous
SO2 concentrations reflect local sulfur emis-
sions and were most highly correlated with
motor vehicle pollutants.
A major advantage of the ICD data is the
passive monitoring of cardiac tachyarrhyth-
mias. Nevertheless, ICD-detected ventricular
arrhythmias were rare events in this follow-
up, and the small number of subjects with
multiple ICD-detected arrhythmias is a limi-
tation. These patients clearly represent a highly
selected cohort of special interest, because their
previous history of cardiovascular disease might
make them particularly sensitive to the effects
of air pollution episodes. The observed associa-
tions of ventricular tachyarrhythmias with par-
ticulate air pollution in these subjects are large
compared with previous studies. In a mortality
time-series analysis in Boston and five other
cities (Schwartz et al. 1996), each increase of
10 µg/m3 in the 2-day mean PM2.5 was associ-
ated with a 2% increase in the risk of cardio-
vascular mortality. For Boston ICD patients
(Table 2), the observed associations imply an
11% (95% CI, –9 to 35%) increased risk of
potentially fatal ventricular arrhythmias when
scaled to the same 10 µg/m3 in the 2-day
mean PM2.5 concentrations. Thus, the ICD
patients had a risk of potentially life-threaten-
ing ventricular tachyarrhythmias associated
with fine particles that was more than five
times the risk of cardiovascular death in the
general population. Among those at the high-
est risk—those with a recent prior ventricular
arrhythmia—the increased risk of a new ven-
tricular tachyarrhythmia was 97% (95% CI,
46–165%) associated with each 10-µg/m3
increase in PM2.5.
Conclusions
We found that ventricular tachyarrhythmias
among patients with ICDs increased with air
pollution on the same and previous days, but
these associations did not reach statistical sig-
nificance. However, among patients with a
recent tachyarrhythmia, the increased risk of a
follow-up ventricular tachyarrhythmia associ-
ated with air pollution was large and statisti-
cally significant. These observations suggest
that air pollution may act in combination with
a cardiac electrical instability to increase the
risk for ventricular tachyarrhythmias. Among
such acutely vulnerable ICD patients, there
was an exposure response with PM2.5, BC,
NO2, CO, and SO2, which we interpret as
indicators of mobile source pollution, and also
evidence of an association with SO4, which we
interpret as an indicator of power plant and
other stationary fossil fuel combustion sources.
ICDs have proven to be highly effective
in reducing the risk of death in patients with
high risk of cardiac arrhythmias. The passive
monitoring of arrhythmias by these devices
has provided a rich resource for understanding
the role of air pollution episodes as potential
triggers of these events.
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CORRECTION
Some counts of observations (Tables 1 and
2) and the interquartile range of SO4 (Tables
1, 2, and 3) were for 1-day rather than 2-day
mean in the original manuscript published
online. They have been corrected here.